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Suicide is a common phenomenon affecting people of all ages. There is a strong relationship
between suicidal ideation and depressive disorders. Increasing number of studies suggest
that epigenetic modifications in certain brain areas are the main mechanism through which
environmental and genetic factors interact with each other contributing to the development
of mental disorders. To verify this hypothesis, some epigenetic marks: H3K9/14ac, HDAC2/
3, H3K27me2 and Sin3a, as well as p-S421-MeCP2/MeCP2 were examined. On the other
hand, BDNF protein level were studied.
Materials and methods
Western blot analysis were performed in the frontal cortex (FCx) and hippocampus (HP) of
suicide victims (n = 14) and non-suicidal controls (n = 8). The differences between groups
and correlations between selected proteins were evaluated using Mann-Whitney U-test and
Spearman’s rank correlation.
Results
Statistically significant decrease in H3K9/14ac (FCx:#~23%;HP:#~33%) combined with
increase in HDAC3 (FCx:"~103%;HP:"~85% in HP) protein levels in suicides compared to
the controls was shown. These alterations were accompanied by an increase in H3K27me2
(FCx:"45%;HP:"~59%) and Sin3a (HP:"50%) levels and decrease in p-S421-MeCP2/
MeCP2 protein ratio (HP:#~55%;FCx:#~27%). Moreover, reduced BDNF protein level
(FCx:#~43%;HP:#~28%) in suicides was observed. On the other hand, some significant cor-
relations (e.g. between H3K9/14ac and HDAC2 or between BDNF and p-S421-MeCP2/
MeCP2) were demonstrated.
Conclusions
Our findings confirm the role of epigenetic component and BDNF protein in suicidal behav-
ior. Lowered BDNF protein level in suicides is probably due to decrease in histone
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acetylation and increased level of factors related with deacetylation and methylation pro-
cesses, including MeCP2 factor, which may operate bidirectionally (an activator or inhibitor
of transcription).
Introduction
Suicide is an important public health issue of the 21st Century. Each year, it affects around 800
thousand people globally [1]. According to the World Health Organization (WHO), suicidality
is a principal reason of injury and mortality all over the world, ranking as the 2nd leading cause
of death in 15–29 year old group [2]. Suicidal behavior (SB) is conditioned by multiple factors
which comprises complex relationships between character traits, psychosocial and environ-
mental factors as well as genetic background [3, 4].
Among many risk factors for suicidality, mental disorders (especially affective disorders)
seems to be the most critical. It is believed that up to 60% of those who commit suicide meet
the diagnostic criteria for major depressive disorders (MDD). On the other hand, depression
and suicide are also strongly interrelated [2]. Similarly, suicidal thoughts are significant cause
of death in bipolar disorders (BD). Approximately 25–50% of BD patients undertake suicide
attempts and 15% of these ends as successful [5]. Other psychiatric conditions (e.g., anxiety,
psychotic and panic disorders, schizophrenia) are not insignificant in the development of SB
as well [6]. Regardless of mental illness-based mechanisms, it seems that there are another
independent brain factors contributing to suicides [4].
In the last dozen or so years, research on pathomechanisms of suicide and SB has been
intensified. At the cellular level, numerous changes in the tissues of suicide victims have been
demonstrated (see [7] for review). For example, our previous studies have revealed significant
alterations in the N-Methyl-D-aspartate receptor (NMDAR) complex activity. A reduced affin-
ity of zinc and magnesium to NMDAR accompanied by an increase in GluN2A and decrease
of GluN2B and PSD-95 protein level in the hippocampus were shown [8]. Furthermore, in sui-
cides was observed altered level of several proteins (zinc transporters; ZnTs) involving in the
regulation of zinc homeostasis which was correlated with a decreased GluA1 and GluN2A
expression in the frontal cortex [9]. Except that, numerous studies on the relationship between
genetic factors and suicides point to changes in single genes [10]. What’s more, recent large
genome-wide association studies (GWAS) have revealed certain genes (genetic variants) that
predispose suicidal attempts or complete suicides [11–13]. On the other hand, numerous mor-
phological changes (e.g. thinner prefrontal and anterior cingulate cortex) in the brains of sui-
cides, as a consequence of altered expression and synthesis of neurotrophic factors, were
described [14].
One of the most important neurotrophins, which plays critical role in the proper brain
development and their functioning is the brain-derived factor (BDNF). It is hypothesized that
pathological changes in BDNF expression are responsible for neuropsychological deficits
related to stress, depression or suicide [15]. A reduced BDNF level both in the body fluids as
well as brain structures was shown in the rodents subjected to various stress procedures [15–
19]. Similarly, clinical studies was demonstrated lower serum or plasma BDNF concentration
in patients diagnosed with major depression and manifesting suicidal behavior [15]. Post mor-
tem studies indicate decreased BDNF level in the hippocampus and prefrontal cortex and no
changes in the enthorinal cortex and the amygdala of completed suicides [19, 20]. On the
other hand, in depressed patients downregulation of BDNF in anterior cingulate cortex,
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Abbreviations: BDNF, brain-derived neurotrophic
factor; H3K9/14ac, histone H3 acetylated at lysines
9 and 14; HDAC2/3, histone deacetylase 2/3;
MeCP2, Methyl-CpG-binding protein 2; p-S421-
MeCP2, MeCP2 phosphorylated at serine 421;
H3K27me2, dimethylated histone H3 at lysine 27;
Sin3a, SIN3 transcription regulator family member
A; FCx, frontal cortex; HP, hippocampus.
amygdala and caudal brainstem was reported [21, 22]. It should be emphasized that lower
BDNF levels in anterior cingulate cortex were found in subjects who had been exposed to early
life adversity and/or died by suicide in relation to nonsuicide decedents and no reported child-
hood adversity [3]. While the links between disturbed BDNF level and suicidal behavior are
relatively well documented, the transcriptional regulation of BDNF is not fully explained [23].
Human (like rodent) BDNF gene contain nine exons (I-IX). It has been proven that each
exon is regulated by its own unique promoter, conferring temporal and spatial control of
BDNF expression in an activity-dependent manner. As a result, initially more than 10 different
transcripts can be formed, but finally all of them are translated into an identical BDNF protein
[23]. Changes in BDNF gene and further gene expression steps, such as modifications of the
BDNF precursor protein, are also important for the end effect. In the context of mood disor-
ders, two single nucleotide polymorphisms (SNPs): the Val66Met (also designed as: rs6265,
G196A; located in the pro-BDNF region) and BE5.2 (located in a cis-regulatory region control-
ling the activity of a BDNF promoter) that reduce evoked release of BDNF (e.g. in the hippo-
campus) seems to be the most important [24–26]. An increasing number of studies suggests
that the BDNF gene expression can be effectively regulated by epigenetic modifications (with-
out changes in DNA sequence). On the other hand, the role of epigenetic changes in the patho-
mechanism of mood disorders is increasingly confirmed [27, 28]. In this connection,
understanding the epigenetic regulation of the BDNF expression can give a new light on the
diagnosis and treatment of these disorders in the future [23, 29].
So far, DNA methylation is the most frequently studied epigenetic modification of the
human genome in the context of mental disorders, including SB [30–33]. Among others, an
associations between stress-related genes like SKA2 (kinetochore-associated protein 2), NR3C1
(Nuclear Receptor Subfamily 3 Group C Member 1), GABAAα1 (Gamma-aminobutyric acid A
receptor α1 subunit), hGR (human glucocorticoid receptor), SAT1 (diamine acetyltransferase
1) or HTR2A (5-Hydroxytryptamine Receptor 2A) in brain multiple cohorts and suicidal
behavior were demonstrated [34–38]. Further studies also showed a significant effect of hyper-
methylation of BDNF and tropomycin receptor kinase B (TRKB) promoters on their expres-
sion, resulting in brain plasticity dysfunction [39, 40]. Moreover, the increasing global
methylation in the prefrontal cortex of suicide completers was also observed [4]. Interestingly,
methylomic profiling of brain samples revealed differentially methylated regions (DMRs) in
certain genetic loci (especially upstream of the PSORS1C3 gene) associated with suicidal
depression. More detailed study of these samples indicated hypomethylated areas within these
DMRs and discrete modules of co-methylated loci related with polygenic risk burden only for
suicide attempt (not major depression) [32]. On this basis, Murphy et al. (2020) conclude the
existence of coordinated alterations in DNA methylation that are associated with SB [33].
On the other hand, numerous modifications of histones and enzymes involved in their for-
mation have been described in post mortem brain tissues [32]. Distinct histone modifications
are related with genomic features. For example, two histone marks: H3K4me3 (trimethylated
lysine 4 of histone H3) and H3K9ac (acetylated lysine 9 of histone H3) are associated with
active gene promoter, while repressed genes are characterized by H3K9 and H3K27 dimethyla-
tion or trimethylation [41].
Based on the available data, it can be concluded that epigenetic modifications are an impor-
tant factors that critically influence gene expression (also those crucial for the proper function-
ing of the brain, like BDNF) and may have a significant impact on the appearance of suicide-
related phenotypes. However, this problem requires a more detailed examination. So far, most
studies on histone modification have concerned only predisposing genes while genome-wide
approaches should be applied. Comprehensive study of histone modifications across the
genome will allow to examine epigenetically altered neural circuits as the primary cause of
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suicide. In addition, examining the role of epigenetic mediators (such as MeCP2) will allow a
better understanding of the nature of this phenomenon and interrelationships between indi-
vidual epigenetic factors. Knowledge of the most important risk factors increasing the likeli-
hood of committing suicide and its pathophysiology is indispensable for the formation of
appropriate preventive systems.
The present study was undertaken to examine whether the several modifications of his-
tones, and the enzymes involved in their formation (H3K9/14ac, H3K27me2, HDAC2,
HDAC3, Sin3a) in the hippocampus and frontal cortex may play a role in suicidal behavior.
Moreover, the MeCP2 protein level, which regulates genes (including BDNF) transcription by
binding to methylated DNA and recruiting enzymes that modify histones, was studied. Finally,
the level of BDNF protein was determined in the same brain tissues.
Materials and methods
Tissue collection
Brain tissues [Hippocampus (HP) and Frontal Cortex (FCx)–Brodmann area 10] were
obtained from 14 non-diagnosed psychiatrically suicide victims (mean age ± SEM; 29.21 ±
3.594) and 8 unexpected sudden death controls (31.0 ± 4.89) at the time of autopsy in the
Department of Forensic Medicine, Jagiellonian University Medical College [Grant no. 6P05B
142 20 from the State Committee for Scientific Research, approved by the Ethics Committee
(2001–2004)]. The ethics committee approved a waiver of informed consent for this study
knowing that participants will not and cannot be identified (we only have the data disclosed in
this manuscript). The study subjects comprised 8 females and 14 males. According to the avail-
able medical history, both suicide and control subjects included in this study were not treated
for any chronic central nervous system diseases (three cases of suicide death resulted from a
single drug overdose). Demographic characteristics of each subject are described in Table 1.
Western blot analysis
The tissue samples were prepared according to the standard protocol [8]. After total protein
determination by BCA method (Pierce Biotechnology, USA), samples containing 30 μg of total
proteins and loading buffer were fractionated on 8–12% (depending on the molecular mass of
analyzed protein) polyacrylamide gels and transferred to a nitrocellulose membrane (Bio-Rad,
Germany). Non-specific signals were blocked using 1% blocking solution (BM Chemilumines-
cence Western Blotting Kit; Mouse/Rabbit, Roche, Switzerland). Next, the membranes were
incubated overnight at 4˚C with primary antibodies: anti-acetyl-Histone H3 (Lys9/14; H3K9/
14ac) rabbit IgG antibody (Active Motif, USA; dilution 1:1,000); anti-HDAC2 mouse IgG2a
(Cell Signaling, USA; dilution 1:1,000); anti-HDAC3 mouse IgG2a (Cell Signaling, USA; dilu-
tion 1:1,000); anti-BDNF rabbit antibody (Santa Cruz Biotechnology, USA; dilution 1:200);
anti-MeCP2 rabbit polyclonal IgG (Santa Cruz Biotechnology, USA; dilution 1:300); anti-p-
S421-MeCP2 rabbit polyclonal antibody (Abgent, USA; dilution 1:1,000); anti-di-methyl-His-
tone H3 (Lys27; H3K27me2) rabbit polyclonal antibody (Cell Signaling, USA; dilution
1:1,000) or anti-Sin3a rabbit antibody (Active Motif, USA; dilution 1: 1,000). After that, the
membranes were washed 3 times for 10 min in Tris-buffered saline with Tween (TBS-T) and
incubated at room temperature with goat anti-rabbit or anti-mouse IgG-HRP conjugated anti-
bodies (Bio-Rad, Germany; dilution 1: 20,000) for 60 min. All antibodies used, both primary
and secondary, were dissolved in 0.5% blocking solution (Roche, Switzerland). After incuba-
tion with secondary antibodies the blots were washed 4 times for 5 min with TBS-T and devel-
oped by enhanced chemiluminescence reaction (Roche, Switzerland). The protein signals were
visualized and measured using a Fuji-Las 1000 system and Fuji Image Gauge ver. 4.0 software.
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As a control for transfer and loading, β-actin was assessed on each membrane. For this, mouse
monoclonal anti-β-actin antibody (Sigma Aldrich, Germany; dilution 1:10,000) was used.
Final results represent the ratio of the optical density of a particular protein to the optical den-
sity of β-actin present in the same sample. Representative Western blots are shown in Fig 1.
Statistical analysis
The data was evaluated by GraphPad PRISM software (ver. 5.0, San Diego, CA, USA). The
Shapiro-Wilk test was performed in order to evaluate the normal distribution of quantitative
data. Because not all data showed the normal distribution we used the Mann-Whitney U-test
to determine differences between studied groups. For the same reason, correlations between
quantitative variables were assessed by Spearman’s rank correlation coefficient. To minimize
the likelihood of a type 1 error, multiple testing correction was performed following Benja-
mini-Hochberg method. p<0.05 was considered as statistically significant.
Results
Immunoreactive bands corresponding to molecular masses of 17, 55/50, 14, 55/52, 17, 155,
and 42 kDa were revealed for H3K9/14ac, HDAC2/3, BDNF, p-S421-MeCP2/MeCP2,
H3kK27me2, Sin3a and β-actin, respectively (Fig 1).
As shown in Fig 2, the amount of H3K9/14ac immunoreactivity from suicide victims was
significantly lower than that of the control subjects, both in HP [#33.1%, p = 0.0441, Mann-
Table 1. Demographic characteristics of controls and suicide subjects.
Group Sex (male/female) Age (years) Cause of death
Control
1 M 17 Cranial/brain injure
2 F 44 Road accident
3 M 20 Carbon monoxide poisoning
4 M 54 Myocardial infarction
5 M 29 Homicide
6 M 42 Myocardial infarction
7 F 21 Homicide
8 F 21 Road accident
Suicide
1 M 33 Hanging
2 M 29 Hanging
3 F 21 Hanging
4 M 17 Hanging
5 M 47 Hanging
6 M 19 Jump under train
7 F 21 Self-poisoning/drug overdose (doxepine + clomipramine)
8 F 29 Jumping
9 M 20 Self-poisoning/drug overdose (hydroxyzine + perazine)
10 M 55 Hanging
11 F 20 Self-drowning
12 F 55 Self-poisoning/drug overdose (diazepam + ethanol)
13 M 24 Jumping
14 M 19 Hanging
M-male; F-female
https://doi.org/10.1371/journal.pone.0239335.t001
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Whitney U-test] (Fig 2A) and FCx [#22.8%, p = 0.009, Mann-Whitney U-test] (Fig 2F). Con-
versely, there was a robust increase in the HDAC3 protein level [HP: "85.3%, p = 0.010 (Fig
2C); FCx: "102.8%, p = 0.014 (Fig 2H), Mann-Whitney U-test] and a slight, but insignificant
increase in HDAC2 protein level (Fig 2B and 2G, respectively) in suicides. Interestingly, our
results showed significant correlations between H3K9/14ac and HDAC2 protein level in the
both studied brain regions of suicide victims [HP: r = -0.657, p = 0.0107; FCx: r = -0.626,
p = 0.022; Spearman’s rank correlation] (Fig 2D and 2I, respectively). Furthermore, there was
significant correlation between H3K9/14ac and HDAC 3 protein level in the hippocampus
[r = -0.560, p = 0.037; Spearman’s rank correlation] (Fig 2F), but not in the frontal cortex
(Fig 2J).
Subsequent analysis revealed significant decrease in BDNF protein level of suicide group
compared to the matched controls in HP [#28%, p = 0.005, Mann-Whitney U-test] (Fig 3A)
and FCx [#42.03%, p = 0.019, Mann-Whitney U-test] (Fig 3E). Simultaneously, significant
reduction in p-S421-MeCP2/MeCP2 protein ratio were demonstrated [HP: ~55%, p = 0.002
(Fig 3B); FCx: ~27%, p = 0.010 (Fig 3F), Mann-Whitney U-test]. Our findings also indicated
significant positive correlations between BDNF level and p-S421-MeCP2/MeCP2 protein ratio
in the hippocampus of suicide victims [r = 0.783, p = 0.0009 (Fig 3C)] and also between BDNF
and H3K9/14ac protein levels, both in HP [r = 0.772, p = 0.001 (Fig 3D); Spearman’s rank cor-
relation] and FCx [r = 565, p = 0.035 (Fig 3H), Spearman’s rank correlation].
Fig 1. Immunoblots of MeCP2, p-S421-MeCP2, H3K27me2, Sin3a, H3K9/14ac, HDAC2, HDAC3, BDNF and β-
actin from representative subjects used in the analysis. Each well was loaded with 30μg of total protein.
Abbreviations: CON–non-suicidal control; SD–suicide.
https://doi.org/10.1371/journal.pone.0239335.g001
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What’s more, significant changes in the H3K27me2 [HP: "58.9%, p = 0.0221 (Fig 4A); FCx:
"45.0%, p = 0.018 (Fig 4E), Mann-Whitney U-test] and Sin3a [HP: "50.0%, p = 0.028 (Fig 4B),
Mann-Whitney U-test] protein levels of suicide victims when compared to the sudden death
controls were noted. Spearman’s rank correlation revealed strong negative correlation between
MeCP2 ratio and Sin3a level, both in the hippocampus [r = -0.736, p = 0.0027 (Fig 4C); Spear-
man’s rank correlation] and frontal cortex [r = -0.692, p = 0.006 (Fig 4G); Spearman’s rank
correlation], and no significant relationship between HDAC2 protein and MeCP2 ratio (Fig
4D and 4H).
Discussion
A first major finding of this study is that suicidal behavior is accompanied by decreased his-
tone acetylation combined with changes in HDAC2/3 protein level, both in the frontal cortex
and hippocampus of post mortem brain.
Typically, histone acetylation is related to gene activation. Addition of acetyl group to N-
terminal lysine, especially on histone H3 or H4, leads to chromatin relaxation and allows the
transcriptional machinery to initiate gene expression. These enzymatic reaction is catalysed by
acetyltransferases (HATs), while removal of acetyl group from histone tails, condensation of
chromatin and silencing of gene transcription are accelerated by histone deacetylases
(HDACs) [28]. Genome-wide studies have shown that histone acetylation mainly concern
gene promoters [42]. In our work, we decided to examine alterations in global levels of H3K9/
14ac protein. A large body of evidence has suggested that histone acetylation in several brain
structures has an overall adaptive role in stress and antidepressant responses. Covington et al.
showed that histone acetylation (H3K14ac) is first temporarily lowered and next persistently
increased in the nucleus accumbens (NAc) after chronic social defeat stress, and that this is
correlated with a reduction in HDAC2 levels [43]. Similar changes were also indicated in the
NAc of depressed patients in post mortem investigation [42]. In the hippocampus, contrary to
what was observed in the NAc after chronic social defeat stress, there was (following a transient
increase) a sustained decrease in H3K14ac. These alterations were reversed by antidepressant
(imipramine) treatment [44]. Similarly, in rats subjected to the chronic unpredictable or vari-
able stress model lowered H3 or H4 acetylation on lysine 9 or 12 (respectively) were observed
[45, 25–46]. On the other hand, exposition to some acute stressors resulted in an increase in
histone (phospho)acetylation in certain subareas of HP in rodents [47, 48].
NAc and HP are most widely studied brain structures in the context of mood disorders and
epigenetics together, whereas only a few papers concern changes in other regions of the corti-
cal-striatal-limbic circuit in the brain. In the amygdala, increased H3K14ac level in the chronic
social defeat stress model in mice (both 1 and 24 f after the last defeat) was demonstrated.
After longer periods H3 acetylation returned to baseline [44]. Interestingly, acute social defeat
stress in rats reduced transiently H3 acetylation in the amygdala, while there was no effect of
chronic stress [49]. Simultaneously, global levels of histone acetylation in the prefrontal cortex
do not seem to change after acute or chronic stress in rodent models [44, 49]. On the one
hand, it seems to be in opposition to our results, but on the other hand, it may suggest that sui-
cidal behavior is a consequence of another adverse factors, hence their effect on the brain
structures may be different.
Fig 2. Correlation between H3K9/14ac and HDAC2/3 in the hippocampus (left panel; A-E) and frontal cortex (right
panel; F-J) of suicide victims. Relative protein level of H3K9/14ac (A, F), HDAC2 (B, G) and HDAC3 (C, H) in non-
suicide control subjects (n = 8) and suicide victims (n = 14). Data are expressed as investigated protein levels in
relation to β-actin (mean R.O.D values ± SEM). Correlation analysis for the H3K9/14ac and HDAC2 (D, I) and H3K9/
14ac and HDAC3 (E, J) in suicide victims.
https://doi.org/10.1371/journal.pone.0239335.g002
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In the light of the above data, it can be suggested that histone hypoacetylation in the brain is
a common characteristic of mood disturbances and its hyperacetylation (especially H3) may
be an indicator of the antidepressant activity of compounds. However, it must not be forgotten
that any changes in chromatin acetylation have serious consequences in the activity of key
genes. In present study we showed that decreased level of H3K9/14ac, both in the HP and FCx
was positively correlated with the BDNF protein. The role of BDNF in both pathophysiology
and therapy of depressive disorders seems to be strongly confirmed [50, 51]. Similarly, the rela-
tionship between BDNF and suicidal behavior is well documented [3, 19, 20, 52]. Most pub-
lished data indicate a significant decrease in BDNF levels in suicides, which is why our
observations are consistent with previous studies [3, 19, 20, 53, 54]. Although BDNF seems to
be a promising marker of suicidal behavior, it should be remembered that its expression in var-
ious tissues (including brain) may be region-specific [3, 19, 20]. Similarly, some differences
between blood components were observed in suicides [52]. Altered BDNF level in suicides
may be the consequence of persistent (like Val66Met polymorphism) or variable genome
changes (like higher methylation status in BDNF gene promoter or changed histone code due
to post-translational changes in chromatin) (see [55]).
The relationship between histone acetylation and BDNF expression has been the subject of
numerous previous studies. For example, Zheng et al. revealed that decreased of H3K14 acety-
lation as well as increased of HDAC2 and HDAC1 levels are related to downregulation of hip-
pocampal BDNF expression in offspring from gestational stress dams [56]. Contrary, after
electroconvulsive shock (ECS) treatment, acetylation of H3 (but not H4) was increased which
was necessary to regulate BDNF expression [57]. There is also proven the influence of histone
H3 acetylation on NMDA/ERK/MSK1/2 pathway which is related with BDNF synthesis [58].
Our work revealed lowered H3K9/14ac accompanied by an increase in the HDAC2 and
HDAC3, both in FCx and HP of suicide victims as compared to the sudden death controls.
Previously, it was shown a decline in the HDAC2 protein in the nucleus accumbens (NAc) in
clinical depression [59]. In turn, other authors found an elevated HDAC2 and HDAC5 mRNA
level in white blood cells of MDD patients in the depressive episode [43]. Even more varied
changes in HDACs expression pattern were revealed in the studies on animal models of
depression and after antidepressant administration (see [28] for review). It is well known that
HDAC2 plays essential role in the development, cell cycle progression and gene regulation
whereas HDAC3 can downregulate p53 (nuclear transcription factor) and thereby modulate
cell growth and apoptosis [60]. It seems that in suicides acetylation of H3 is downregulated but
on the other hand HDAC 3 and 2 are upregulated. In the frontal cortex HDAC2 and HDAC3
may play role in genes silencing and apoptosis exaggeration. Meanwhile in the hippocampus
HDAC3, but not HDAC2, may regulate gene which are responsible for adaptation of central
nervous system, but it need to be examined. Furthermore, downregulation of acH3 and upre-
gulation of HDAC2/3 may be corresponding with each other and be bound with methylation
processes.
Another important findings of this study is that suicidal behavior is characterized by serious
changes in histone H3 methylation (H3K27me2) status as well as chromatin-associated protein
(MeCP2/p-S421-MeCP2) which binds to region of methylated CpG in genome and play essen-
tial role in the gene expression. MeCP2 (Methyl-CpG-Binding Protein 2) has two domains, one
Fig 3. Correlation between BDNF and H3K9/14ac or p-S421-MeCP2/MeCP2 ratio in the hippocampus (left panel; A-D)
and frontal cortex (right panel; E-H) of suicide victims. Relative protein level of BDNF (A, E) and p-S421-MeCP2/MeCP2 (B,
F) in non-suicide control subjects (n = 8) and suicide victims (n = 14). Data are expressed as investigated protein levels in
relation to β-actin (mean R.O.D values ± SEM). Correlation analysis for the BDNF and p-S421-MeCP2/MeCP2 (C, G) and
BDNF and H3K9/14ac (D, H) in suicide victims.
https://doi.org/10.1371/journal.pone.0239335.g003
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recognize methylated cytosine (5mC)–MBD and another terminate the transcription—TRD,
so this molecule may be viewed as transcriptional modulator. MeCP2 is functionally associated
with a variety of signal transduction pathways in the cell and plays a key role in the maturation
of neurons, synaptogenesis and nervous system development. In response to neural stimula-
tion, MeCP2 is phosphorylated on serine 421 (S421), leading to its activation [61]. It was
found that MeCP2, depending on the current needs of neuron, acts as a repressor or activator
of transcription [62]. Knowledge of epigenetic and metabolic mechanisms by which MeCP2
protein controls the expression of target genes is still restricted. There is evidence that in rest-
ing neurons MeCP2 regulates gene expression by binding to methylated CpG dinucleotides in
gene promoters, where it forms complexes with other repressors, including histone deacety-
lases (e.g., HDAC1, HDAC2) and histone methyltransferases (HMT), and co-repressor Sin3a.
As a consequence, chromatin condenses, limiting the access of transcriptional factors and
enzymes to gene promoters. Conversely, neuronal activation evokes MeCP2 phosphorylation
which results in its release from the promoter region and dissociation of the corepressor com-
plex [63]. Due to the fact that MeCP2 can actively binds to methylated DNA as well as causes
further modification of chromatin (alone or by recruiting other factors), this protein is called
multi-talented epigenetic factor or global chromatin regulator [64]. Importantly, the existence
of numerous phosphorylation (and other post-translational modifications) sites within the
polypeptide chain of MeCP2 allow very precise regulation of its activity and adaptation to cur-
rent needs of the cell [65]. Mutations in the gene encoding MeCP2 are associated with Rett
syndrome, Angelman syndrome, mental retardation, MDD and addiction [66, 67]. In cocaine
addiction, MeCP2 selectively regulate BDNF, CBP (CREB-binding protein) and CAMK2d
(calcium/calmodulin dependent protein kinase II delta) genes transcription [68]. The mecha-
nism of MeCP2-dependent regulation of the BDNF gene suggests enhanced BDNF expression
in the absence of MeCP2 [65].
MeCP2 is probably multidimensionally involved in the pathophysiology of depression.
Hutchinson et al. revealed crucial role of MeCP2 phosphorylation (p-MeCP2-Ser421) in antide-
pressant properties of citalopram and imipramine. Increasing level of MeCP2 caused depressive
behavior and lack of S421 phosphorylation lead to absence to antidepressant action of this
drugs [69, 70]. Moreover, p-MeCP2-Ser421 is necessary for deactivation of repressive HDAC/
Sin3a complex and activation of transcription [63]. Neuronal activation is necessary for MeCP2
phosphorylation which lead to hyperacetylation and releasing of chromatin [62]. These fact sug-
gest that MeCP2 and methylation of DNA may induce changes in acetylation/deacetylation pat-
tern. MeCP2 also interacts with Sin3a and H3K27me2. Sin3a is a transcription regulator which
works together with REST (Restrictive Element-1 Silencing Transcription Factor) corepressor
and regulates cell cycle progression and gene inhibition. Di-methylation (me2) at histone H3
lysine 9/27 (H3K9/K27) is related with euchromatic gene repression. Genome-wide studies
have revealed a widespread H3K9/K27 methylation alterations at the promoters of many genes
in two animal models of depression (social defeat and social isolation), the majority of which
are reversed by chronic antidepressant treatment [42, 71]. Another study showed that an
increase in the H3K27me2 level was correlated with decreased BDNF expression in the hippo-
campus after chronic social defeat stress, and this induction of repressive methylation was per-
sistent despite chronic imipramine treatment [72]. The association of H3 methylation with
reduced BDNF level in the brain was also confirmed by other authors [42, 73].
Fig 4. Correlation between p-S421-MeCP2/MeCP2 ratio and Sin3a or HDAC2in the hippocampus (left panel; A-D) and frontal
cortex (right panel; E-H) of suicide victims. Relative protein level of H3K27me2 (A, E) and Sin3a (B, F) in non-suicide control
subjects (n = 8) and suicide victims (n = 14). Data are expressed as investigated protein levels in relation to β-actin (mean R.O.D
values ± SEM). Correlation analysis for the MeCP2 ratio and Sin3a (C, G) and MeCP2 ratio and HDAC2 (D, H) in suicide victims.
https://doi.org/10.1371/journal.pone.0239335.g004
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In our work, an increase of H3K27me2, and decrease of p-MeCP2-Ser421/MeCP2 protein
ratio in suicide tissue was observed. Interestingly, in the hippocampus (but not in the frontal
cortex) elevated Sin3a protein level was also shown. On the other hand, a significant negative
correlation between the level of MeCP2 and Sin3a was revealed in both examined structures,
which indicates the complexity of epigenetic interactions in the brain. It seems that in the hip-
pocampus and frontal cortex epigenetic machinery operates in a different structure-dependent
manner. Although we have noted a decreased BDNF level both in FCx and HP, it seems that
BDNF expression is regulated by different epigenetic factors depend to structure.
According to our knowledge in HP BDNF may be regulated by corepressor complex with
MeCP2/HDAC3/Sin3a and decreasing level of p-MeCP2-Ser421 may suggest role of BDNF
and neuronal silencing by decreased neuronal activity and gene transcription. In the frontal
cortex BDNF is also reduced but it seems to be the effect of gene inhibition based on its meth-
ylation. Considering the above knowledge and data from studies indicating both an increase in
global DNA methylation [4] and the presence of hypomethylated regions at selected genetic
loci in suicides [32, 33], it seems justified and necessary to further investigate the role of
MeCP2 in the context of mood disorders. HDAC2 increased in HP impaired special memory
and synaptic plasticity [74] and with HDAC5 plays important role in MDD patients [75]. We
suggest that in FCx HDAC2 may regulate different genes not only BDNF but also involved on
cortical abnormalities and metabolic impaired but it need to be examined.
In summary, our study, for the first time describe alterations in the BDNF levels in suicide
victims on the background of serious and multidimensional epigenetic changes both in the
frontal cortex and hippocampus. The obtained results contribute to a better understanding of
the mechanisms underlying the suicidal behavior. On the other hand, we are fully aware of
some limitations of this study, especially those related to the subjects’ description. First of all,
based on the available demographic characteristics, we do not know whether suicide victims
suffered from depression. We only have information that suicides included in the study were
not treated for depression, which is not synonymous with the fact that they did not suffer from
it. On the other hand, it is estimated that about 60% of suicides met the diagnostic criteria for
MDD [2]. Furthermore, it has been revealed that suicide completers more likely suffered from
MDD than suicide attempters [9]. This allows us to conclude about the potential coexistence
of depressive disorders in the study subjects for whom no diagnostic information was avail-
able. The support of this hypothesis may be the results of our previous study, which showed a
similar direction of biochemical changes in the prefrontal cortex of patients diagnosed with
MDD and suicides (with limited medical history) [9]. On the other hand, lacking of psychiatric
diagnosis for the suicide victims, it cannot be ruled out that the observed epigenetic changes
are a consequence of other factors than depression.
Equally important, three of the fourteen suicide subjects died from a drug overdose. We
assume that the use of these drugs (in the following combinations: doxepine + clomipramine;
hydroxyzine + perizine; diazepam + ethanol) was incidental and the suicide completers had
not previously used these drugs regularly. However, it is worth noting that at least one of these
three cases used a combination of typical antidepressant drugs. Although, comparison of the
results obtained from these 3 subjects (alone or in combination) with the results obtained
from the remaining 11 tissues did not indicate statistically significant differences (results not
presented), we cannot exclude the possibility that changes in the levels of the studied proteins
may result (at least partially) from the effects of drug medications.
Another limitation of this study is also the lack of information on potential comorbidities,
postmortem interval (PMI) or pH of tissues, which could also critically affect the final result of
this study.
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Despite the above-mentioned most important limitations of this study, we believe that pre-
sented results will contribute to deepening our understanding of the role of epigenetic mecha-
nisms in suicidal behavior and shed new light on previous research.
Conclusions
Our findings confirm the role of epigenetic component and BDNF protein in suicidal behav-
ior. Lowered BDNF protein level in suicides is probably due to decrease in histone acetylation
and increased level of factors related with deacetylation and methylation processes, including
MeCP2 factor, which may operate bidirectionally (an activator or inhibitor of transcription).
The mechanisms of epigenetic regulation of gene expression in the brain seems to be very
complicated, multidirectional and structure-dependent, therefore, further, extended studies
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